BECKLEY, W.Va., June 5, 2026 /PRNewswire/ -- How can flowers convey sympathy when words fall short? A HelloNation article featuring Steven Webb, a memorial flower...
Vancouver, Canada, June 05, 2026 (GLOBE NEWSWIRE) --
Free spins casinos are seeing increased interest as players look for offers such as 50 no deposit free spins, to $200 no deposit bonus 200 free spins real money that provide an opportunity to experience casino games without making an immediate deposit. Many users are increasingly seeking promotional rewards that offer greater flexibility while reducing the risks often associated with trying a new online casino.
The iconic Seoul-based brand introduces a first-of-its-kind flagship where cutting-edge architecture meets AI-based, made-for-you beautySEOUL, South Korea, June 5, 2026 /PRNewswire/ -- After 18 months...
New GeneSight ® Mental Health Monitor Reveals 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
New GeneSight ® Mental Health Monitor Reveals 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
Trusted by eight of the world's top 10 retailers and CPG companies, Tredence powers $2 trillion in global retail revenue, delivering AI transformation at...
HONG KONG, June 2, 2026 /PRNewswire/ -- Manulife Hong Kong today announced a strategic partnership with Alibaba Cloud, a leading global provider of AI infrastructure...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options
NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (NYSE:NVO), Altimmune, Inc. (NASDAQ:ALT), SelectQuote, Inc. (NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.